Detalhe da pesquisa
1.
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease.
Immunity
; 56(3): 669-686.e7, 2023 03 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36889306
2.
A broad and potent neutralization epitope in SARS-related coronaviruses.
Proc Natl Acad Sci U S A
; 119(29): e2205784119, 2022 07 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35767670
3.
A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.
J Immunol
; 207(1): 344-351, 2021 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34183368
4.
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody.
PLoS Pathog
; 16(12): e1009089, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33275640
5.
S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate.
Nat Chem Biol
; 15(10): 983-991, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31332308
6.
Artificial Cysteine S-Glycosylation Induced by Per-O-Acetylated Unnatural Monosaccharides during Metabolic Glycan Labeling.
Angew Chem Int Ed Engl
; 57(7): 1817-1820, 2018 02 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29237092
7.
Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4.
Structure
; 2024 Mar 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38537643
8.
Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4.
bioRxiv
; 2023 Nov 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38045427
9.
Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution.
Sci Signal
; 16(798): eabk3516, 2023 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37582161
10.
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift.
bioRxiv
; 2023 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-37162858
11.
Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses.
Cell Host Microbe
; 31(1): 97-111.e12, 2023 01 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36347257
12.
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways.
iScience
; 25(9): 104914, 2022 Sep 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35971553
13.
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection.
bioRxiv
; 2022 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-33821273
14.
A broad and potent neutralization epitope in SARS-related coronaviruses.
bioRxiv
; 2022 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35313576
15.
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection.
Sci Transl Med
; 14(637): eabi9215, 2022 03 23.
Artigo
Inglês
| MEDLINE | ID: mdl-35133175
16.
Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques.
Sci Transl Med
; 14(657): eabl9605, 2022 08 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35947674
17.
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease.
bioRxiv
; 2022 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35291291
18.
Broadly neutralizing antibodies target the coronavirus fusion peptide.
bioRxiv
; 2022 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35441178
19.
Broadly neutralizing antibodies target the coronavirus fusion peptide.
Science
; 377(6607): 728-735, 2022 08 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35857439
20.
One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening.
bioRxiv
; 2021 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33758848